DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Response to comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’

Journal Article · · eLife
ORCiD logo [1];  [2];  [3];  [4]; ORCiD logo [1];  [5];  [1];  [1];  [6]
  1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  2. Univ. of Wisconsin, Milwaukee, WI (United States)
  3. Univ. of North Carolina, Chapel Hill, NC (United States)
  4. Vanderbilt Univ., Nashville, TN (United States)
  5. Univ. of Tennessee, Knoxville, TN (United States)
  6. Univ. of Cincinnati, OH (United States)

Early in the SARS-CoV-2 pandemic, we compared transcriptome data from hospitalized COVID-19 patients and control patients without COVID-19. We found changes in procoagulant and fibrinolytic gene expression in the lungs of COVID-19 patients. These findings have been challenged based on issues with the samples. We have revisited our previous analyses in the light of this challenge and find that these new analyses support our original conclusions.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE; Novo Nordisk; Bristol Myers Squibb; Bayer
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
1855666
Journal Information:
eLife, Journal Name: eLife Journal Issue: na Vol. 11; ISSN 2050-084X
Publisher:
eLife Sciences Publications, Ltd.Copyright Statement
Country of Publication:
United States
Language:
English